InMode Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a INMD research report →
Companywww.inmodemd.com
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
- CEO
- Moshe Mizrahy
- IPO
- 2019
- Employees
- 599
- HQ
- Yokne'am, IL
Price Chart
Valuation
- Market Cap
- $888.29M
- P/E
- 10.19
- P/S
- 2.37
- P/B
- 1.34
- EV/EBITDA
- 5.06
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 77.84%
- Op Margin
- 21.31%
- Net Margin
- 23.27%
- ROE
- 13.28%
- ROIC
- 10.11%
Growth & Income
- Revenue
- $370.50M · -6.16%
- Net Income
- $93.83M · -48.24%
- EPS
- $1.45 · -36.68%
- Op Income
- $85.39M
- FCF YoY
- -36.15%
Performance & Tape
- 52W High
- $16.74
- 52W Low
- $12.72
- 50D MA
- $13.89
- 200D MA
- $14.46
- Beta
- 1.98
- Avg Volume
- 910.03K
Get TickerSpark's AI analysis on INMD
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | Anghel Michael J | other | 0 |
| Mar 18, 26 | Anghel Michael J | other | 1,000 |
| Mar 18, 26 | Mizrahy Moshe | other | 0 |
| Mar 18, 26 | Kenneth Nadav | other | 0 |
| Mar 18, 26 | Kenneth Nadav | other | 1,500 |
| Mar 18, 26 | Kreindel Michael | other | 0 |
| Mar 18, 26 | Malca Yair | other | 0 |
| Mar 18, 26 | Malca Yair | other | 30,000 |
| Mar 18, 26 | Malca Yair | other | 20,500 |
| Mar 18, 26 | Dennison Michael Howard | other | 0 |
Our INMD Coverage
We haven't published any research on INMD yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate INMD Report →